CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Down 97.4% in March

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a large drop in short interest in March. As of March 31st, there was short interest totalling 10,800 shares, a drop of 97.4% from the March 15th total of 414,600 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 108.0 days.

CanSino Biologics Stock Performance

Shares of CASBF remained flat at C$3.20 during trading hours on Tuesday. The business has a 50-day moving average price of C$4.17 and a 200 day moving average price of C$3.87. CanSino Biologics has a 1 year low of C$1.98 and a 1 year high of C$4.90.

About CanSino Biologics

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.